MDS 3.0 updates

Angie Szumlinski
|
October 10, 2024
MDS 3.0 Updates: High-Risk Drug Classes and COVID-19 Vaccination Tracking
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
